Mazen M. Dimachkie, “Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond”, rrnmf, vol. 3, no. 2, pp. 13–26, Jun. 2022, doi: 10.17161/rrnmf.v3i2.16304.